This website is intended for individuals living with relapsed/refractory multiple myeloma in United States.

Who Can Participate

You may be able to participate in the dreaMM8 study if:

  • You are at least 18 years old.
  • You are diagnosed with multiple myeloma.
  • You have been previously treated with at least one prior line of multiple myeloma therapy including a lenalidomide-containing regimen. (Lenalidomide must have been administered for at least 2 consecutive cycles.)
  • Your multiple myeloma progressed (got worse) during or after your most recent therapy.

There are other eligibility requirements that the study doctor will review with you.

Answer a few questions to see if you may qualify for the dreaMM8 study.

Answer Questions